Bibliography
- Shaw JE , SicreeRA, ZimmetPZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract.87(1), 4–14 (2010).
- Carino GP , MathiowitzE. Oral insulin delivery. Adv. Drug Del. Rev.35(2–3), 249–257 (1999).
- Clore J , Thurby-HayL. Basal insulin therapy. Curr. Diab. Rep.4(5), 342–345 (2004).
- Arbit E , KidronM. Oral insulin: the rationale for this approach and current developments. J. Diabetes Sci. Technol.3(3), 562–567 (2009).
- Binder C , LauritzenT, FaberO, PrammingS. Insulin pharmacokinetics. Diabetes Care7(2), 188–199 (1984).
- Ward PD , TippinTK, ThakkerDR. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Tech. Today3(10), 346–358 (2000).
- Feng SS . New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine (Lond.)1(3), 297–309 (2006).
- Feng SS . Nanomedicine: nanoparticles of biodegradable polymers for cancer diagnosis and treatment. COSMOS – Interdiscipl. J. Sci. Singa. Natl Acad. Sci.4(2), 185–201 (2008).
- Gershonov E , GoldwaserI, FridkinM, ShechterY. A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl]3-insulin. J. Med. Chem.43(13), 2530–2537 (2000).
- Calceti P , SalmasoS, WalkerG, Bernkop-SchnürchA. Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur. J. Pharm. Sci.22(4), 315–323 (2004).
- Scott-Moncrieff JC , ShaoZ, MitraAK. Enhancement of intestinal insulin absorption by bile salt–fatty acid mixed micelles in dogs. J. Pharm. Sci.83(10), 1465–1469 (1994).
- Wang B , MaR, LiuGet al. Glucose-Responsive micelles from self-assembly of poly(ethylene glycol)-b-poly(acrylic acid-co-acrylamidophenylboronic acid) and the controlled release of insulin. Langmuir 25(21), 12522–12528 (2009).
- Niu M , LuY, HovgaardL, WuW. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int. J. Nanomed.6(1), 1155–1166 (2011).
- Cui FD , TaoAJ, CunDM, ZhangLQ, ShiK. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J. Pharm. Sci.96(2), 421–427 (2007).
- Ramesan RM , SharmaCP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev. Med. Devices6(6), 665–676 (2009).
- Feng SS , ZhaoL, TangJ. Nanomedicine for oral chemotherapy. Nanomedicine (Lond.)6(3), 407–410 (2011).
- Chaudhury A , DasS. Recent Advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS Pharm. Sci. Tech.12(1), 10–20 (2011).
- Yeh TH , HsuLW, TsengMTet al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 32(26), 6164–6173 (2011).
- Sonaje K , Lin K-J, Wang JJ et al. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv. Funct. Mater20(21), 3695–3700 (2010).
- Lin YH , ChungCK, ChenCT, LiangHF, ChenSC, SungHW. Preparation of nanoparticles composed of chitosan/poly-r-glutamic acid and evaluation of their permeability through Caco-2 Cells. Biomacromolecules6(2), 1104–1112 (2005).
- Lin YH , MiFL, ChenCTet al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8(1), 146–152 (2007).
- Sonaje K , LinYH, JuangJH, WeySP, ChenCT, SungHW. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials30(12), 2329–2339 (2009).
- Yin L , DingJ, HeC, CuiL, TangC, YinC. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials30(29), 5691–5700 (2009).
- Sonaje K , ChenYJ, ChenHLet al. Enteric-coated capsules filled with freeze-dried chitosan/poly(γ-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 31(12), 3384–3394 (2010).
- Sonaje K , LinKJ, WeySPet al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 31(26), 6849–6858 (2010).
- Arbit E . The physiological rationale for oral insulin administration. Diabetes Technol. Ther.6(4), 510–517 (2004).
- Gossain V . Insulin analogs and intensive insulin therapy in Type 1 diabetes. Int. J. Diabetes Dev. Ctries.23(2), 26–36 (2003).